Search
for
Sort by
Research 301–330 of 1000+
- Dermatological manifestations associated with pregnancy
- Acne in Dark Skin
- Secondary amenorrhea
- Androgens and androgen receptor action in skin and hair follicles
- Finasteride Treatment of Hair Loss in Women
- Androgen treatment of postmenopausal women
- Relationships Between Biochemical Markers of Hyperandrogenism and Metabolic Parameters in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Menopause
- Gonads
- Vitamins
- Skin manifestations of hyperandrogenism: an update
- Androgens and Antiandrogens
- Physiologic changes and dermatoses of pregnancy
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Hirsutism in the Adolescent Female
- New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats
- Regulation of the human hair cycle
- Physiological perspective of Hirsutism in Unani Medicine: An Overview and Update
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Serum irisin level in patients with acne vulgaris
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities
- Insulin Resistance and Polycystic Ovary Syndrome
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Dissolving microneedles: an advanced approach for transdermal drug delivery
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities
- Androgens in women